Three-year follow-up of high-risk keratoplasty following fine-needle diathermy of corneal neovascularization combined with bevacizumab
Open Access
- 6 January 2022
- journal article
- letter
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 260 (7) , 2383-2385
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (FOR2240, FOR2240)
- European Cooperation in Science and Technology (BM1302, BM1302)
- Horizon 2020 Framework Programme (ARREST BLINDNESS)
- Studienstiftung des Deutschen Volkes
- Universitätsklinikum Köln
This publication has 5 references indexed in Scilit:
- Cutting Edge: Novel Treatment Options Targeting Corneal Neovascularization to Improve High-Risk Corneal Graft SurvivalCornea, 2021
- Corneal Crosslinking to Regress Pathologic Corneal Neovascularization Before High-Risk KeratoplastyCornea, 2020
- Risk of Corneal Graft Rejection After High-risk Keratoplasty Following Fine-needle Vessel Coagulation of Corneal Neovascularization Combined With Bevacizumab: A Pilot StudyTransplantation Direct, 2019
- Split Cornea Transplantation for 2 RecipientsOphthalmology, 2011
- Corneal Neovascularization as a Risk Factor for Graft Failure and Rejection after KeratoplastyOphthalmology, 2010